About Retractable Technologies, Inc. 
Retractable Technologies, Inc.
Pharmaceuticals & Biotechnology
Retractable Technologies, Inc. designs, develops and manufactures safety medical products for the healthcare industry. The Company markets VanishPoint and PatientSafe products. The VanishPoint products are designed specifically to prevent needle stick injuries and to prevent reuse. The VanishPoint safety products include tuberculin, insulin and allergy antigen VanishPoint syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL and 10mL VanishPoint syringes, and the VanishPoint autodisable syringe. It also sells the VanishPoint intravenous catheter, the VanishPoint blood collection tube holder and the VanishPoint blood collection set. The PatientSafe syringe reduces the risk of bloodstream infections resulting from catheter hub contamination. Its PatientSafe products include 3mL, 5mL, 10mL, 20mL, 30mL and 60mL syringes, and the PatientSafe Luer cap. Its product designs include retractable needle syringe designs, retractable needle designs and retractable needle dental syringe designs.
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 6 Schemes (3.52%)
Foreign Institutions
Held by 6 Foreign Institutions (0.22%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Mr. Thomas Shaw
Chairman of the Board, President, Chief Executive Officer
Mr. John Fort
Vice President, Chief Financial Officer, Treasurer, Director
Mr. Walter Bigby
Independent Director
Mr. Darren Findley
Independent Director
Mr. Marco Laterza
Independent Director
Ms. Amy Mack
Independent Director
Revenue and Profits:
Net Sales:
10 Million
(Quarterly Results - Jun 2025)
Net Profit:
0 Million
Pharmaceuticals & Biotechnology
USD 24 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.42
-20.78%
0.31






